Clinical Presentations

A pooled analysis of the data from the 3 pivotal trials showed reductions in A1C and LDL-C when Welchol was added to metformin-based, sulfonylurea-based, and insulin-based therapies in patients with type 2 diabetes. In these studies….

The ACE/AACE road map for the achievement of glycemic goals in patients with diabetes recommends a wide range of therapies, including oral drugs, incretin mimetics, and insulin for the achievement of glycemic control….

The systems in which most physicians work do not allow sufficient time for providing evidence-based medicine at every visit, to make sure patients understand the evidence, and to encourage patients to incorporate evidence into their lives…

Evaluation of the Kaiser Permanente Northern California population indicated that patients with diabetes are also very likely to have both dyslipidemia and hypertension….

This graph compares the incidence of type 1 and type 2 diabetes among children and adolescents younger than 20 years by age group and race/ethnicity. In the year 2002–2005, among children younger than 10 years, the estimated rate of new cases of type 1 diabetes was….

The prevalence of Type 2 diabetes mellitus (DM) has increased dramatically over the past several decades, suggesting significant contributions by changes in diet and lifestyle over time….

Plasminogen is an acute phase protein and precursor to plasmin, which digests fibrin, the essential portion of a blood clot….

Adiponectin is an adipocyte-derived protein that plays an important role in glucose and lipid metabolism….

Over twelve and half million Americans currently have heart disease and 1.1 million are expected to have a serious heart event each year….

Diabetes mellitus can lead to many acute and chronic complications. The chronic complications are mainly the result of longstanding damage to blood vessels….